Bard Announces International Launch of Premounted SAXX Renal Stent.Health/Medical Writers MURRAY HILL, N.J.--(BW HealthWire)--July 7, 2000 C.R. Bard, Inc. (NYSE-BCR) announced today the international launch of its premounted SAXX Renal Stent Delivery System. The SAXX Renal System combines the SAXX(TM)stent and the Opti-Plast(TM)XT balloon catheter balloon catheter n. A catheter with an inflatable balloon at its tip, used especially to expand a partially obstructed blood vessel or bodily passage and to measure blood pressure in a blood vessel. Also called balloon-tip catheter. to create a unique and flexible low-profile combination. The Opti-Plast XT delivery balloon is made of proprietary Nydex material, a non-compliant, scratch-resistant nylon that is ideally suited for stent delivery and placement. The SAXX stent is made of high-grade stainless steel stainless steel: see steel. stainless steel Any of a family of alloy steels usually containing 10–30% chromium. The presence of chromium, together with low carbon content, gives remarkable resistance to corrosion and heat. , with a laser cut design providing high radial strength and flexibility with minimal shortening. "By combining the leading edge stent and PTA PTA or parent-teacher association: see parent education. technologies, we believe that Bard has created the optimal renal stent delivery system," stated William H. Longfield, chairman and chief executive officer. "Bard takes pride in our long history of solving the clinical needs of our customers and their patients. The launch of the SAXX Renal System will further strengthen our position as a leader in the field of endovascular therapy," Longfield concluded. The system's 6F compatibility and ultra-low profile allow it to smoothly traverse tortuous anatomy. The SAXX Renal System is available in catheter lengths of 75 and 120 cm. The stent comes in a range of diameters from 5 to 7 mm and lengths from 13 to 20 mm. The SAXX Renal System is CE marked and available for immediate sale in Europe. C. R. Bard C. R. Bard, Inc. (NYSE: BCR) is one of the large S&P 500 companies of the United States, a surgical specialties and hospital medical device manufacturer in Murray Hill, New Jersey. It is named after its founder, who sold the company within only a few years of its founding. , Inc., (www.crbard.com) headquartered in Murray Hill, New Jersey
|
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion